1.The feasibility of unilateral neck exploration for parathyroid adenoma
Maode LI ; Rixiang GONG ;
Chinese Journal of General Surgery 2001;0(10):-
Objective To investigate the feasibility of unilateral neck exploration for parathyroid adenoma. Methods The clinical data of preoperative image localization and intraoperative unilateral neck exploration of 15 cases of parathyroid adenoma from 1996 to 2002 in our hospital were analyzed retrospectively. Results Unilateral neck explorations of the 15 cases were performed successfully with the guidance of preoperative ultrasonography , CT, MRI and 99m Tc MIBI scans, and the treatment effect was satisfactory. Conclusion Unilateral neck exploration of parathyroid adenoma could be feasible if accurate preoperative image localizations are available.
2.Screening for endocrine exophthalmos-associated genes/cDNA fragments.
Jianguo ZHENG ; Ying ZHANG ; Congye SHU ; Rixiang GONG
Journal of Biomedical Engineering 2006;23(2):383-387
This study was conducted to screen the endocrine exophthalmos-associated genes or cDNA fragments and provide a basis for exploring the pathogenesis. The cDNA from the thyroid tissues of patients with hyperthyroidism and endocrine exophthalmos (HT&EE) was used as tester cDNA, and that from the thyroid tissues of patients with HT but free from EE was used as driver cDNA. The subtractive PCR products between tester and driver cDNA were obtained through two cycles of subtraction hybridization and two cycles of PCR by using suppression subtractive hybridization, and then were inserted into pT-Adv, a cloning vector. The ligated DNAs were transformed into E. coli DH5alpha competent cells and incubated for proper blue/white color development. Forty-eight white colonies were randomly picked and their inserts were colony PCR amplified. The PCR product from one of the colonies contained two inserts; the others contained single insert, having a size of 0.2 kb to 2 kb. The inserts of transformants were arrayed on nylon membrane. After cDNA/Rsa I digestion the thyroid tissues of patients with HT, and of patients with HT&EE, were labeled with digoxigenin; the nylon membranes were then hybridized respectively with the two cDNA probes for a high throughput screening for positive clones. The clones which were hybridized with the cDNA probe of HE&EE patients but not hybridized with the probe of the HT patients or showed only faint signal of hybridization, were chosen as positive clones and their inserts were candidates for the endocrine exophthalmos genes or cDNA fragments. About 50% of the clones were confirmed as positive clones. The cDNA fragments in the positive clones were the endocrine exophthalmos-associated genes or cDNA fragments. Endocrine exophthalmos
Cloning, Molecular
;
DNA, Complementary
;
genetics
;
Graves Disease
;
genetics
;
Humans
;
Polymerase Chain Reaction
3.Familial nonmedullary thyroid cancinoma in two pedigrees with nine cases.
Yanping GONG ; Jingqiang ZHU ; Rixiang GONG
Chinese Journal of Medical Genetics 2013;30(3):381-381
Carcinoma, Papillary
;
diagnosis
;
genetics
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pedigree
;
Thyroid Neoplasms
;
diagnosis
;
genetics
4.Therapy for Graves' ophthalmopathy.
Jianguo ZHENG ; Xia ZHANG ; Rixiang GONG ; Ji WANG ; Tianzhi TAN
Journal of Biomedical Engineering 2004;21(5):876-879
Graves' ophthalmopathy (GO) is also called thyroid-related eye disease, infiltrative ophthalmopathy, which is related with the autoimmunity of thyroid, especially hyperthyroidism. Its morbidity ragnes from five percent to ten percent of hyperthyroidism, and the morbidity of male patients is higher than that of the female patients. The treatment of severe GO is a difficult task for doctors. The therapeutic effect is not always satisfactory. In order to solve this knotty problem, researchers have been devoting themselves to the development of new therapeutic methods. Here, the development of the therapies for GO is introduced, and the trends of treatments are prospected.
Combined Modality Therapy
;
Exophthalmos
;
etiology
;
radiotherapy
;
therapy
;
Graves Disease
;
complications
;
radiotherapy
;
therapy
;
Humans
;
Immunoglobulins
;
therapeutic use
;
Prednisolone
;
therapeutic use
6.Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer.
Rui HUANG ; Xiajuan MA ; Suping LI ; Da MU ; Rixiang GONG ; Anren KUANG
Journal of Biomedical Engineering 2010;27(5):1080-1084
This study sought to probe the feasibility of instituting a radioiodide treatment for androgen-independent prostate cancer by adenovirus transfer of the hNIS gene. A recombinant adenovirus, Ad-CMV-NIS, that expressed the NIS gene under the control of cytomegalovirus (CMV) promoter was constructed. In vitro, after infection with Ad-CMV-NIS,PC-3 prostate cancer cells exhibited an uptake of perchlorate-sensitive iodide, approximately 120 times higher than that exhibited by negative control Ad-CMV-GFP-infected cells. The half-time of efflux was 26.6 min. Clonogenic assays demonstrated that Ad-CMV-NIS-infected cancer cells were selectively killed by exposure to 131I. In vivo, Ad-CMV-NIS infected tumors showed significant radioiodine accumulation (16.30 +/- 8.72)% ID/g at 2h postinjection) with an effective half-life of 5.4h. The tumor could be clearly visualized by 131I scintigraphy. These data indicate that infection with Ad-CMV-NIS is an efficient way to induce radioiodide uptake in vitro and in vivo, thus suggesting that NIS-based gene therapy has the potential for use in androgen-independent prostate cancer.
Adenoviridae
;
genetics
;
metabolism
;
Genetic Therapy
;
methods
;
Humans
;
Iodine Radioisotopes
;
therapeutic use
;
Male
;
Prostatic Neoplasms
;
genetics
;
metabolism
;
radiotherapy
;
Symporters
;
genetics
;
Transfection
;
methods